Standards Needed for Novel Ingredients Utilized in Increasing Number of Products
(PRWeb August 07, 2012)
Read the full story at http://www.prweb.com/releases/functionalfoods/dietarysupplements/prweb9778268.htm
DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide, is pleased to announce the appointment of Dr Ling Su as...
(PRWeb August 07, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9777342.htm
The FDA accepted TherapeuticsMD Investigational New Drug application and now the Company can proceed with Phase III clinical trials for its product TX12002HR for hormone therapy.
(PRWeb August 07, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9777203.htm
In a recent interview with Sparkah, Healthcare Data Solutions' CEO Tim Slevin discusses the rising costs of messaging to Prescribers, as well as compliance solutions for the medical device and...
(PRWeb August 07, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9777097.htm
Formedix, a leading provider of clinical trial automation software and consultancy services extends their family of Transform for EDC products, with a new addition which integrates with Perceptive...
(PRWeb August 07, 2012)
Read the full story at http://www.prweb.com/releases/Transform/forDataLabs/prweb9776424.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments